The -786 T/C polymorphism of the NOS3 gene is associated with elite performance in power sports.
The NOS3 gene is a candidate to explain individual variations in health and exercise related phenotypes. We compared genotypic and allelic frequencies of the NOS3 -786 T/C polymorphism (rs2070744) in three groups of men of the same Caucasian (Spanish) descent: (i) elite endurance athletes (cyclists, runners; N = 100); (ii) elite power athletes (jumpers, throwers, sprinters; N = 53) and (iii) non-athletic controls (N = 100). The frequency of the TT genotype was significantly higher in power athletes (57%) than in the endurance (33%, P = 0.017) or control group (34%, P = 0.026). The frequency of the T allele was also higher in power sportsmen (71%) than in their endurance (55%, P = 0.003) and control referents (56%, P = 0.015). No differences were observed between control and endurance groups. In summary, the -786 T/C polymorphism of the NOS3 gene seems to be associated with elite performance in power-oriented athletic events (throwing, jumping, sprinting), with the T allele exerting a beneficial effect. The mechanism by which this allele variant might benefit power performance remains to be elucidated.
Gómez-Gallego
Félix
F
Universidad Europea de Madrid, 28670 Villaviciosa de Odón, Madrid, Spain.
Ruiz
Jonatan R
JR
Buxens
Amaya
A
Artieda
Marta
M
Arteta
David
D
Santiago
Catalina
C
Rodríguez-Romo
Gabriel
G
Lao
José I
JI
Lucia
Alejandro
A
D000328:Adult; D056352:Athletes; D054874:Athletic Performance / Q000502:physiology; D016022:Case-Control Studies; D004252:DNA Mutational Analysis; D005787:Gene Frequency; D005838:Genotype; D006801:Humans; D008297:Male; D052250:Nitric Oxide Synthase Type III / Q000235:genetics*; D020641:Polymorphism, Single Nucleotide / Q000502:physiology; D011401:Promoter Regions, Genetic; D055070:Resistance Training; D013177:Sports / Q000502:physiology; D055815:Young Adult
C496314:NOS3 protein, human; D052250:Nitric Oxide Synthase Type III
J Appl Physiol (1985). 2002 May;92(5):2005-11
11960951
Am J Cardiol. 2000 Sep 15;86(6):628-34
10980213
J Anat. 2008 Mar;212(3):306-18
18221329
Exerc Sport Sci Rev. 2006 Jan;34(1):36-41
16394813
Nature. 2002 Feb 14;415(6873):755-6
11845199
Circulation. 1999 Jun 8;99(22):2864-70
10359729
Pharmacol Rev. 1991 Jun;43(2):109-42
1852778
Circulation. 1998 Dec 15;98(24):2709-15
9851957
Hypertension. 2002 Apr;39(4):919-22
11967250
Clin Chem. 2005 Jul;51(7):1137-44
15890894
Genomics. 1994 Jan 15;19(2):350-7
7514568
J Physiol. 2004 Dec 1;561(Pt 2):623-35
15358808
Antioxid Redox Signal. 2009 Aug;11(8):1913-28
19203224
Exerc Sport Sci Rev. 2000 Jan;28(1):10-4
11131681
J Card Fail. 2009 Apr;15(3):191-8
19327620
Hypertension. 1999 Jan;33(1 Pt 2):591-7
9931171
Circ Res. 1999 Apr 16;84(7):840-5
10205152
Med Sci Sports Exerc. 2009 Jan;41(1):35-73
19123262
J Muscle Res Cell Motil. 2006;27(8):577-84
17051348
Diabetes. 2007 Nov;56(11):2690-6
17682093
J Clin Invest. 2009 Mar;119(3):448-50
19306501
Circulation. 1999 Sep 21;100(12):1291-7
10491373
J Physiol. 2009 Apr 1;587(Pt 7):1527-34
19237423
J Appl Physiol (1985). 2006 Jan;100(1):258-65
16166235
Hum Mol Genet. 2006 Mar 15;15(6):979-87
16461337
Hum Genet. 1998 Jul;103(1):65-9
9737779
Int J Sports Med. 2006 Dec;27(12):951-8
16761221
Am J Hum Genet. 2003 Sep;73(3):627-31
12879365
Scand J Med Sci Sports. 2010 Feb;20(1):e188-94
19422651
Scand J Med Sci Sports. 2008 Aug;18(4):485-90
18067521
FEBS Lett. 2000 Apr 7;471(1):45-50
10760510
Circulation. 1995 Aug 1;92(3):320-6
7634444
J Clin Invest. 1991 Nov;88(5):1663-71
1719029
Hypertension. 2000 Nov;36(5):885-9
11082161
Am J Physiol. 1997 Jul;273(1 Pt 2):H405-10
9249515